Erratum: Thiolated silicone oil: Synthesis, gelling and mucoadhesive properties (Acta Biomaterialia (2015) 16 (169-177) DOI: 10.1016/j.actbio.2015.01.020);Thiolated silicone oil: Synthesis, gelling and mucoadhesive properties

Acta Biomaterialia

Volumn 16, Issue 1, 2015, Pages 169-177

  Partenhauser, Alexandra ^a   Laffleur, Flavia ^a   Rohrer, Julia ^a   Bernkop Schnch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Antiflatulence; Gelling; Mucoadhesiveness; Silicone oil; Thiomers

Indexed keywords

AMINO ACIDS; DISEASES; GELATION;

3-MERCAPTOPROPIONIC ACID; ANTIFLATULENCE; DYNAMIC VISCOSITIES; GELLING; GELLING PROPERTIES; MUCOADHESIVE PROPERTIES; MUCOADHESIVENESS; SILICONE OIL; THIOMERS; TOTAL WORK;

SILICONES;

3 MERCAPTOPROPIONIC ACID; CARBOXYLIC ACID; CHITOSAN; CYANAMIDE; CYSTEINE CONJUGATE; IODINE; OXIDIZING AGENT; POLYMER; SILICONE OIL; THIOL GROUP; THIOLATED SILICONE OIL; THYMIDINE DIPHOSPHATE; UNCLASSIFIED DRUG; ADHESIVE AGENT; GEL; LIGAND; OXAZINE DERIVATIVE; RESAZURIN; SOLUTION AND SOLUBILITY; THIOL DERIVATIVE; XANTHENE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CHEMICAL MODIFICATION; CONJUGATE; CONTROLLED STUDY; CROSS LINKING; DISULFIDE BOND; GASTROINTESTINAL MUCOSA; GELLING; INTESTINE MUCOSA; MAXIMUM DETACHMENT FORCE; MUCOADHESION; NONHUMAN; ONE POT SYNTHESIS; OXIDATION; PRIORITY JOURNAL; RESAZURIN ASSAY; SHEAR STRESS; SMALL INTESTINE MUCOSA; SURFACE AREA; THIOLATION; TOTAL WORK OF ADHESION; VISCOELASTICITY; VISCOMETRY; ANIMAL; BIOMECHANICS; CACO 2 CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GEL; HUMAN; IN VITRO STUDY; INTESTINE; METABOLISM; MUCUS; PIG; SOLUTION AND SOLUBILITY; SYNTHESIS; TIME; VISCOSITY; YOUNG MODULUS;

3-MERCAPTOPROPIONIC ACID; ADHESIVES; ANIMALS; BIOMECHANICAL PHENOMENA; CACO-2 CELLS; CELL SURVIVAL; ELASTIC MODULUS; GELS; HUMANS; IN VITRO TECHNIQUES; INTESTINES; LIGANDS; MUCUS; OXAZINES; SILICONE OILS; SOLUTIONS; SULFHYDRYL COMPOUNDS; SUS SCROFA; TIME FACTORS; VISCOSITY; XANTHENES;

EID: 84930946726     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.05.030     Document Type: Erratum

References (39)

1. Kaplan MA, Prior MJ, Ash RR, McKonly KI, Helzner EC, Nelson EB. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort: a randomized controlled trial. Arch Fam Med 1999;8:243.
2. Hanauer SB, DuPont HL, Cooper KM, Laudadio C. Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort. Curr Med Res Opin 2007;23:1033-43.
3. Asl SM, Sivandzadeh GR. Efficacy of premedication with activated dimethicone or N-Acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterol 2011;17:4213.
4. de la Portilla F, Ynfante I, Ferndez A, Bejarano D, Carranza G. Improved quality of anorectal endoluminal ultrasonography using emulsion of dimethicone. Dis Colon Rectum 2003;46:1436-7.
5. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebocontrolled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002;16:1641-8.
6. Coffin B, Bortolloti C, Bourgeois O, Denicourt L. Efficacy of a simethicone, activated charcoal and magnesium oxide combination (Carbosymag) in functional dyspepsia: results of a general practice-based randomized trial. Clin Res Hepatol Gastroenterol 2011;35:494-9.
7. Ogilvie AL, Atkinson M. Does dimethicone increase the efficacy of antacids in the treatment of reflux oesophagitis? J R Soc Med 1986;79:584-7.
8. Smart HL, Atkinson M. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis. J R Soc Med 1990;83:554-6.
9. Torrado G, Garcia-Arieta A, de los Rios F, Menendez JC, Torrado S. Quantitative determination of dimethicone in commercial tablets and capsules by Fourier transform infrared spectroscopy and antifoaming activity test. J Pharm Biomed Anal 1999;19:285-92.
10. Brecevic L, Bosan-Kilibarda I, Strajnar F. Mechanism of antifoaming action of simethicone. J Appl Toxicol 1994;14:207-11.
11. Rider JA. Experience with the use of a defoaming agent in the treatment of gastrointestinal gas. Ann N Y Acad Sci 1968;150:170-7.
12. Bueno L, Beaufrand C, Theodorou V, Andro-Delestrain M. Influence of simethicone and alverine on stress-induced alterations of colonic permeability and sensitivity in rats: beneficial effect of their association. J Pharm Pharmacol 2013;65:567-73.
13. Ansorg R, Von Recklinghausen G, Heintschel Von Heinegg E. Susceptibility of Helicobacter pylori to simethicone and other non-Antibiotic drugs. J Antimicrob Chemother 1996;37:45-52.
14. Bernkop-Schnch A, Steininger S. Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm 2000;194:239-47.
15. Bernkop-Schnch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005;57:1569-82.
16. Bernkop-Schnch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 2001;71:277-85.
17. Bonengel S, Bernkop-Schnch A. Thiomers-from bench to market. J Control Release 2014. http://dx.doi.org/10.1016/j.jconrel.2014.06.047.
18. Leitner VM, Walker GF, Bernkop-Schnch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 2003;56:207-14.
19. Hintzen F, Laffleur F, Sakloetsakun D, Leithner K, Bernkop-Schnch A. In situ gelling properties of anionic thiomers. Drug Dev Ind Pharm 2012;38:1479-85.
20. Hornof M. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm 2003;55:185-90.
21. Sakloetsakun D, Hombach J, Bernkop-Schnch A. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials 2009;30:6151-7.
22. Han S, Kim Y. Recent development of peptide coupling reagents in organic synthesis. Tetrahedron 2004;60:2447-67.
23. Montalbetti CA, Falque V. Amide bond formation and peptide coupling. Tetrahedron 2005;61:10827-52.
24. Kig W, Geiger R. Eine neue Methode zur Synthese Von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz Von 1-Hydroxy-benzotriazolen. Chem Ber 1970;103:788-98.
25. Windridge G, Jorgensen EC. 1-Hydroxybenzotriazole as a racemizationsuppressing reagent for the incorporation of im-benzyl-L-histidine into peptides. J Am Chem Soc 1971;93:6318-9.
26. Carpino LA, El-Faham A. The diisopropylcarbodiimide/1-hydroxy-7-Azabenzotriazole system: segment coupling and stepwise peptide assembly. Tetrahedron 1999;55:6813-30.
27. Staab HA, Ling M, Dr FH. Darstellung Von Imidazoliden. Synthese Von Amiden, Hydraziden und Hydroxamsren nach der Imidazolidmethode. Chem Ber 1962;95:1275-83.
28. Grassetti R, Murray Jr JF. Determination of sulfhydryl groups with 2, 20-or 4, 40-dithiodipyridine. Arch Biochem Biophys 1967;119:41-9.
29. Egwim IO, Gruber HJ. Spectrophotometric measurement of mercaptans with 4, 40-dithiodipyridine. Anal Biochem 2001;288:188-94.
30. Bernkop-Schnch A, Krajicek ME. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Control Release 1998;50:215-23.
31. Lunter DJ, Rottke M, Daniels R. Oil-in-oil-emulsions with enhanced substantivity for the treatment of chronic skin diseases. J Pharm Sci 2014;103:1515-9.
32. Krauland AH, Hoffer MH, Bernkop-Schnch A. Viscoelastic properties of a new in situ gelling thiolated chitosan conjugate. Drug Dev Ind Pharm 2005;31:885-93.
33. Mortazavi SA, Carpenter BG, Smart JD. A comparative study on the role played by mucus glycoproteins in the rheological behaviour of the mucoadhesive/mucosal interface. Int J Pharm 1993;94:195-201.
34. Mortazavi SA, Smart JD. An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J Control Release 1993;25:197-203.
35. Gum Jr JR, Hicks JW, Toribara NW, Rothe EM, Lagace RE, Kim YS. The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem 1992;267:21375-83.
36. Dekker J, Rossen JW, Bler HA, Einerhand AW. The MUC family: an obituary. Trends Biochem Sci 2002;27:126-31.
37. Johansson MV, Ambort D, Pelaseyed T, Schte A, Gustafsson J, Ermund A, et al. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 2011;68:3635-41.
38. Merga Y, Campbell BJ, Rhodes JM. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Dig Dis 2014;32:475-83.
39. Johansson MEV, Gustafsson JK, Holm?-Larsson J, Jabbar KS, Xia L, Xu H, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2013;63:281-91.